smMIPs have been used to provide a molecular diagnosis to patients with ABCA4-associated Stargardt disease (STGD1) and to capture the entirety of ABCA4 in large cohorts of patients at a high depth of coverage, up to an average of ~700× in large cohorts [18,32]. Here, ABCA4 is linked to severe early-childhood-onset retinal dystrophy.